The Latest Breaking News from Nasdaq

Vuzix Corp (NASDAQ:VUZI) reported a first-quarter sales decline of 36.1% year-over-year to $2.5 million, missing the consensus of $3.4 million. The decrease reflected lower sales of Vuzix smart glasses products, a decline of 37% Y/Y. The gross margin contracted to 26% from 28% in 1Q21. The loss from operations widened to $10.41…

Over the past 3 months, 4 analysts have published their opinion on Caribou Biosciences (NASDAQ:CRBU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

LivePerson (NASDAQ:LPSN) has observed the following analyst ratings within the last quarter:

Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Within the last quarter, Chesapeake Energy (NASDAQ:CHK) has observed the following analyst ratings:

Celsius Holdings (NASDAQ:CELH) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Celsius Holdings beat estimated earnings by 200.0%, reporting an EPS of $0.09 versus an estimate of $0.03.

Trade Desk (NASDAQ:TTD) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Trade Desk beat estimated earnings by 40.0%, reporting an EPS of $0.21 versus an estimate of $0.15.

Wynn Resorts (NASDAQ:WYNN) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Wynn Resorts missed estimated earnings by 5.22%, reporting an EPS of $-1.21 versus an estimate of $-1.15.

Omeros (NASDAQ:OMER) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Omeros beat estimated earnings by 25.35%, reporting an EPS of $-0.53 versus an estimate of $-0.71.

GAINERS: Cara Therapeutics (NASDAQ:CARA) shares closed up 23.76% at $9.22

GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26